Related Experiment Video
Updated: Mar 6, 2026

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models
James C Neil1, Kathryn Gilroy2, Gillian Borland2
1Molecular Oncology Laboratory, Centre for Virus Research, University of Glasgow, Bearsden, Glasgow, G61 1QH, UK. James.Neil@glasgow.ac.uk.
Abstract:
The observation that the Runx genes act as targets for transcriptional activation by retroviral insertion identified a new family of dominant oncogenes. However, it is now clear that Runx genes are 'conditional' oncogenes whose over-expression is growth inhibitory unless accompanied by another event such as concomitant over-expression of MYC or loss of p53 function. Remarkably, while the oncogenic activities of either MYC or RUNX over-expression are suppressed while p53 is intact, the combination of both neutralises p53 tumour suppression in vivo by as yet unknown mechanisms. Moreover, there is emerging evidence that endogenous, basal RUNX activity is important to maintain the viability and proliferation of MYC-driven lymphoma cells. There is also growing evidence that the human RUNX genes play a similar conditional oncogenic role and are selected for over-expression in end-stage cancers of multiple types. Paradoxically, reduced RUNX activity can also predispose to cell immortalisation and transformation, particularly by mutant Ras. These apparently conflicting observations may be reconciled in a stage-specific model of RUNX involvement in cancer. A question that has yet to be fully addressed is the extent to which the three Runx genes are functionally redundant in cancer promotion and suppression.
Insights
Runx genes are conditional oncogenes, acting as growth inhibitors unless combined with MYC overexpression or p53 loss. Their dual role in cancer, promoting or suppressing, depends on cancer stage and specific gene interactions.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Runx genes were initially identified as dominant oncogenes but are now understood as conditional oncogenes.
- Overexpression of Runx genes can inhibit growth unless other genetic events occur, such as MYC overexpression or p53 loss.
Purpose of the Study:
- To elucidate the conditional oncogenic role of Runx genes in cancer development and progression.
- To reconcile apparently conflicting roles of Runx genes in cancer suppression and promotion.
- To investigate the functional redundancy of Runx genes in cancer.
Main Methods:
- Analysis of retroviral insertion data to identify Runx gene targets.
- Investigation of gene interactions, including MYC, p53, and Ras, in the context of Runx gene activity.
- Examination of endogenous Runx activity in MYC-driven lymphoma cells.
- Review of evidence for RUNX gene involvement in human cancers.
Main Results:
- Runx and MYC co-overexpression neutralizes p53 tumor suppression through unknown mechanisms.
- Basal RUNX activity is crucial for the viability and proliferation of MYC-driven lymphoma cells.
- Human RUNX genes are overexpressed in advanced cancers, suggesting a conditional oncogenic role.
- Reduced RUNX activity can paradoxically promote cell immortalization and transformation, especially with mutant Ras.
Conclusions:
- Runx genes exhibit context-dependent roles in cancer, acting as promoters or suppressors based on cellular events and cancer stage.
- A stage-specific model may reconcile the diverse functions of Runx genes in tumorigenesis.
- Further research is needed to determine the functional redundancy of the three Runx genes in cancer.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Non-LTR Retrotransposons
In-vitro Mutagenesis
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

